Remote Patient Monitoring (RPM) Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Remote Patient Monitoring (RPM) Market to surpass USD 125.1 Million by 2030 from USD 23.5 Million in terms of value growing at a CAGR of 38.6% throughout the forecast period, i.e., 2019-30.

Clear

Description

Remote Patient Monitoring (RPM) Market: Market Segments: By Type (Heart Monitors, Breath Monitors, Hematology Monitors, Multi-parameter Monitors, and Other); By Application (Cancer Treatment, Cardiovascular Diseases, Diabetes Treatment, Sleep Disorder, Weight Management and Fitness Monitoring and Other); By End User (Home Care Settings, Hospital/Clinics and Other); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
Product Overview
Remote patient monitoring (RPM) is a technology used to collect medical and health-related data from individuals at one location and electronically transmit it to a healthcare provider at another location. RPM is used to remotely monitor and analyze physiological parameters such as blood oxygen levels, vital signs, blood pressure, heart rate, and blood sugar, which improves the quality of care, quality of life, and allows early prediction of aggravations and exacerbations.
Market Highlights
Remote Patient Monitoring (RPM) Market is expected to project a notable CAGR of 38.6% in 2030.
Remote Patient Monitoring (RPM) Market to surpass USD 125.1 Million by 2030 from USD 23.5 Million in terms of value growing at a CAGR of 38.6% throughout the forecast period, i.e., 2019-30. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market.
Remote Patient Monitoring (RPM) Market: Segments
Multi Parameter Monitors Segment to grow with the highest CAGR of XX.X% during 2019-30
Remote Patient Monitoring (RPM) Market is segmented by type as Heart Monitors, Breath Monitors, Hematology Monitors, Multi-parameter Monitors, and Other. The Heart Monitor segment is estimated to lead the market with a share of over 80.0% of Remote Patience monitoring market in 2018 and this trend is expected to continue during the forecast period. Heart rate monitor is identified as the dominating product sub-segment due to the increasing incidence of cardiac conditions globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors. The multi-parameter remote monitoring devices are used not only by medical professionals but also by the health-conscious population, as sleep and activity monitors fall in these categories.
Remote Patient Monitoring (RPM) Market: Market Dynamics
Drivers
Rising Burden of Chronic Diseases
Chronic heart diseases, diabetes, and chronic respiratory diseases are the leading cause of mortality and morbidity in the world. Chronic care management accounts for 75% of the healthcare costs. The increase in prevalence of chronic conditions places an enormous financial burden on the caregivers. Thus, it reduces the readmissions and prevents avoidable hospitalizations.
Restrain
Stringent Regulatory Framework
The major factors, such as lack of awareness and issues pertaining to price constraints, restrain the growth of RPM market. Despite significant factors driving the wider adoption of remote patient monitoring systems, resistance from the healthcare industry professionals toward the adoption of the patient monitoring system, lack of proper reimbursement policies, and stringent regulatory framework are the challenges faced by the market.
Remote Patient Monitoring (RPM) Market: Regions
Remote Patient Monitoring (RPM) Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Remote Patient Monitoring (RPM) Market in North America led the market in 2018. Increasing geriatric population, the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structure aimed at cutting out of pocket expenditure levels are the major factors attributed to the regional growth. Europe, especially the Western European countries, due to a higher mortality rate and rising demand for low-cost treatment, is expected to remain the second most profit-generating region over the forecast period. Rising demand for in-house monitoring, supportive central data management systems and rising accuracy and efficiency of remote patient monitors are the high impact rendering drivers for the regional growth.
Remote Patient Monitoring (RPM) Market: Key Players
• Abbott Laboratories
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Aerotel Medical Systems
• AMD Global Telemedicine
• Baxter International Inc.
• Boston Scientific Corporation
• GE Healthcare
• Masimo Corporation
• Medtronic PLC
• Omron Corporation
Remote Patient Monitoring (RPM) Market report also contains analysis on:
Remote Patient Monitoring (RPM) Market Segments:
By Type:
• Heart Monitors
• Breath Monitors
• Hematology Monitors
• Multi-parameter Monitors
• Other
By Application:
• Cancer Treatment
• Cardiovascular Diseases
• Diabetes Treatment
• Sleep Disorder
• Weight Management and Fitness Monitoring
• Other Applications
By End User:
• Home Care Settings
• Hospital/Clinics
• Other
• Remote Patient Monitoring (RPM) Market Dynamics
• Remote Patient Monitoring (RPM) Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Related reports:

Global Digital Health Market: Market Segments: By Technology (Mobile Health, Electronic Health Record, Telemedicine & Healthcare Analytics); By Component (Software, Hardware and Services); By End User (B2B & B2C); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

Global Hemodynamic Monitoring Devices Market: Focus on Product, Modality, Setting, and 21 Countries – Analysis and Forecast, 2021-2030

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Remote Patient Monitoring (RPM) Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Remote Patient Monitoring (RPM) Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Remote Patient Monitoring (RPM) Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Remote Patient Monitoring (RPM): Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Heart Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Breath Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Hematology Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Multi-parameter Monitors, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3 By Application: Market Share (2020-2030F)
12.3.1. Cancer Treatment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Cardiovascular Diseases, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Diabetes Treatment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Weight Management and Fitness Monitoring, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.5. Sleep Disorder, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By Type: Market Share (2020-2030F)
12.4.1. Home Care Settings, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Hospital/Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Abbott Laboratories
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Aerotel Medical Systems
13.3. AMD Global Telemedicine
13.4. Baxter International Inc.
13.5. Boston Scientific Corporation
13.6. GE Healthcare
13.7. Masimo Corporation
13.8. Medtronic PLC
13.9. Omron Corporation

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.